Target Price | JPY8,874.00 |
Price | JPY7,341.00 |
Potential |
20.88%
register free of charge
|
Number of Estimates | 16 |
16 Analysts have issued a price target Chugai Pharmaceutical 2026 .
The average Chugai Pharmaceutical target price is JPY8,874.00.
This is
20.88%
register free of charge
JPY12,600.00
71.64%
register free of charge
JPY6,363.00
13.32%
register free of charge
|
|
A rating was issued by 20 analysts: 12 Analysts recommend Chugai Pharmaceutical to buy, 8 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Chugai Pharmaceutical stock has an average upside potential 2026 of
20.88%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion JPY | 1,170.61 | 1,230.73 |
5.33% | 5.14% | |
EBITDA Margin | 46.87% | 51.00% |
16.70% | 8.82% | |
Net Margin | 33.09% | 34.95% |
12.98% | 5.63% |
19 Analysts have issued a sales forecast Chugai Pharmaceutical 2025 . The average Chugai Pharmaceutical sales estimate is
This results in the following potential growth metrics:
19 Chugai Pharmaceutical Analysts have issued a net profit forecast 2025. The average Chugai Pharmaceutical net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share JPY | 235.36 | 261.31 |
18.99% | 11.03% | |
P/E | 27.70 | |
EV/Sales | 8.74 |
19 Analysts have issued a Chugai Pharmaceutical forecast for earnings per share. The average Chugai Pharmaceutical EPS is
This results in the following potential growth metrics and future valuations:
Chugai Pharmaceutical...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.